Enfortumab Vedotin Schedule De-escalation in Metastatic Urothelial Carcinoma
Fox Chase Cancer Center
Fox Chase Cancer Center
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
ImmunityBio, Inc.
Inhibrx Biosciences, Inc
Jonsson Comprehensive Cancer Center
Astellas Pharma Inc
Merck Sharp & Dohme LLC
Hoosier Cancer Research Network
University of Southern California
Alliance for Clinical Trials in Oncology
Carisma Therapeutics Inc
Salubris Biotherapeutics Inc